nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—NR1H4—bile duct—hepatitis B	0.166	0.68	CbGeAlD
Fulvestrant—Hepatitis C—Lamivudine—hepatitis B	0.031	0.0592	CcSEcCtD
Fulvestrant—ESR2—Validated nuclear estrogen receptor beta network—NR0B2—hepatitis B	0.0165	0.0714	CbGpPWpGaD
Fulvestrant—NR1H4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.0157	0.0678	CbGpPWpGaD
Fulvestrant—Cough increased—Adefovir Dipivoxil—hepatitis B	0.0124	0.0236	CcSEcCtD
Fulvestrant—Bone pain—Adefovir Dipivoxil—hepatitis B	0.0118	0.0226	CcSEcCtD
Fulvestrant—EPHX2—blood—hepatitis B	0.0116	0.0476	CbGeAlD
Fulvestrant—NR1H4—liver—hepatitis B	0.0104	0.0425	CbGeAlD
Fulvestrant—ESRRA—blood—hepatitis B	0.0102	0.0417	CbGeAlD
Fulvestrant—ESRRA—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00976	0.0421	CbGpPWpGaD
Fulvestrant—Musculoskeletal pain—Telbivudine—hepatitis B	0.00966	0.0184	CcSEcCtD
Fulvestrant—Hepatic failure—Entecavir—hepatitis B	0.00938	0.0179	CcSEcCtD
Fulvestrant—ESR1—Estrogen Receptor Pathway—NR0B2—hepatitis B	0.00934	0.0404	CbGpPWpGaD
Fulvestrant—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00915	0.0175	CcSEcCtD
Fulvestrant—EPHX2—liver—hepatitis B	0.0091	0.0372	CbGeAlD
Fulvestrant—ESRRA—Nuclear Receptors—HNF4A—hepatitis B	0.00856	0.037	CbGpPWpGaD
Fulvestrant—ESRRA—liver—hepatitis B	0.00797	0.0326	CbGeAlD
Fulvestrant—NR1H4—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00713	0.0308	CbGpPWpGaD
Fulvestrant—Pain in extremity—Telbivudine—hepatitis B	0.00692	0.0132	CcSEcCtD
Fulvestrant—ESRRA—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.00676	0.0292	CbGpPWpGaD
Fulvestrant—CYP3A4—blood plasma—hepatitis B	0.00638	0.0261	CbGeAlD
Fulvestrant—EPHX2—Arachidonic acid metabolism—GGT1—hepatitis B	0.00631	0.0272	CbGpPWpGaD
Fulvestrant—ESR2—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00621	0.0268	CbGpPWpGaD
Fulvestrant—Hepatobiliary disease—Entecavir—hepatitis B	0.00614	0.0117	CcSEcCtD
Fulvestrant—Vasodilation—Lamivudine—hepatitis B	0.00612	0.0117	CcSEcCtD
Fulvestrant—Vasodilation procedure—Lamivudine—hepatitis B	0.00612	0.0117	CcSEcCtD
Fulvestrant—ESR2—blood—hepatitis B	0.00612	0.025	CbGeAlD
Fulvestrant—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00599	0.0114	CcSEcCtD
Fulvestrant—Influenza—Telbivudine—hepatitis B	0.00598	0.0114	CcSEcCtD
Fulvestrant—Hepatitis—Entecavir—hepatitis B	0.00583	0.0111	CcSEcCtD
Fulvestrant—Oedema peripheral—Entecavir—hepatitis B	0.00574	0.011	CcSEcCtD
Fulvestrant—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00569	0.0109	CcSEcCtD
Fulvestrant—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00565	0.0108	CcSEcCtD
Fulvestrant—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00559	0.0107	CcSEcCtD
Fulvestrant—Inflammation—Lamivudine—hepatitis B	0.00554	0.0106	CcSEcCtD
Fulvestrant—ESR2—Nuclear Receptors—HNF4A—hepatitis B	0.00545	0.0235	CbGpPWpGaD
Fulvestrant—Musculoskeletal pain—Lamivudine—hepatitis B	0.00544	0.0104	CcSEcCtD
Fulvestrant—Immune system disorder—Entecavir—hepatitis B	0.00527	0.0101	CcSEcCtD
Fulvestrant—ESR2—Validated nuclear estrogen receptor alpha network—NR0B2—hepatitis B	0.00518	0.0224	CbGpPWpGaD
Fulvestrant—EPHX2—Metapathway biotransformation—AKR1B1—hepatitis B	0.00511	0.0221	CbGpPWpGaD
Fulvestrant—Malnutrition—Entecavir—hepatitis B	0.00508	0.00969	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Telbivudine—hepatitis B	0.00505	0.00963	CcSEcCtD
Fulvestrant—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00495	0.00945	CcSEcCtD
Fulvestrant—NR1H4—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.00494	0.0213	CbGpPWpGaD
Fulvestrant—NR1H4—Recycling of bile acids and salts—ALB—hepatitis B	0.00488	0.0211	CbGpPWpGaD
Fulvestrant—Back pain—Adefovir Dipivoxil—hepatitis B	0.00479	0.00915	CcSEcCtD
Fulvestrant—Hepatitis—Telbivudine—hepatitis B	0.00479	0.00914	CcSEcCtD
Fulvestrant—ESR2—liver—hepatitis B	0.00478	0.0196	CbGeAlD
Fulvestrant—Pharyngitis—Telbivudine—hepatitis B	0.00475	0.00908	CcSEcCtD
Fulvestrant—Connective tissue disorder—Telbivudine—hepatitis B	0.00471	0.00899	CcSEcCtD
Fulvestrant—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00458	0.00874	CcSEcCtD
Fulvestrant—Leukopenia—Entecavir—hepatitis B	0.00454	0.00867	CcSEcCtD
Fulvestrant—Cough—Adefovir Dipivoxil—hepatitis B	0.00432	0.00825	CcSEcCtD
Fulvestrant—ESR2—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.0043	0.0186	CbGpPWpGaD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00429	0.00819	CcSEcCtD
Fulvestrant—Injury—Lamivudine—hepatitis B	0.00425	0.0081	CcSEcCtD
Fulvestrant—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00422	0.00805	CcSEcCtD
Fulvestrant—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00422	0.00805	CcSEcCtD
Fulvestrant—ESR1—blood—hepatitis B	0.00419	0.0171	CbGeAlD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00419	0.00799	CcSEcCtD
Fulvestrant—Malnutrition—Telbivudine—hepatitis B	0.00417	0.00796	CcSEcCtD
Fulvestrant—Infection—Entecavir—hepatitis B	0.00412	0.00786	CcSEcCtD
Fulvestrant—NR1H4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00408	0.0176	CbGpPWpGaD
Fulvestrant—Nervous system disorder—Entecavir—hepatitis B	0.00406	0.00776	CcSEcCtD
Fulvestrant—Back pain—Telbivudine—hepatitis B	0.00403	0.0077	CcSEcCtD
Fulvestrant—Skin disorder—Entecavir—hepatitis B	0.00402	0.00768	CcSEcCtD
Fulvestrant—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00396	0.00757	CcSEcCtD
Fulvestrant—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00393	0.0075	CcSEcCtD
Fulvestrant—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00385	0.00736	CcSEcCtD
Fulvestrant—Insomnia—Entecavir—hepatitis B	0.00375	0.00715	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00368	0.00703	CcSEcCtD
Fulvestrant—Dyspepsia—Entecavir—hepatitis B	0.00365	0.00696	CcSEcCtD
Fulvestrant—Cough—Telbivudine—hepatitis B	0.00364	0.00695	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Entecavir—hepatitis B	0.00358	0.00683	CcSEcCtD
Fulvestrant—Fatigue—Entecavir—hepatitis B	0.00357	0.00682	CcSEcCtD
Fulvestrant—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00356	0.00679	CcSEcCtD
Fulvestrant—Myalgia—Telbivudine—hepatitis B	0.00355	0.00678	CcSEcCtD
Fulvestrant—Chest pain—Telbivudine—hepatitis B	0.00355	0.00678	CcSEcCtD
Fulvestrant—Arthralgia—Telbivudine—hepatitis B	0.00355	0.00678	CcSEcCtD
Fulvestrant—ESR1—Regulation of Telomerase—IFNAR2—hepatitis B	0.00353	0.0152	CbGpPWpGaD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00353	0.00673	CcSEcCtD
Fulvestrant—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00351	0.00671	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00349	0.00666	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Entecavir—hepatitis B	0.00339	0.00647	CcSEcCtD
Fulvestrant—Influenza—Lamivudine—hepatitis B	0.00337	0.00644	CcSEcCtD
Fulvestrant—Nervous system disorder—Telbivudine—hepatitis B	0.00334	0.00637	CcSEcCtD
Fulvestrant—NR1H4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00331	0.0143	CbGpPWpGaD
Fulvestrant—Skin disorder—Telbivudine—hepatitis B	0.00331	0.00631	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00331	0.00631	CcSEcCtD
Fulvestrant—ESR1—liver—hepatitis B	0.00328	0.0134	CbGeAlD
Fulvestrant—Body temperature increased—Entecavir—hepatitis B	0.00328	0.00625	CcSEcCtD
Fulvestrant—Abdominal pain—Entecavir—hepatitis B	0.00328	0.00625	CcSEcCtD
Fulvestrant—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.0032	0.0061	CcSEcCtD
Fulvestrant—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.0032	0.0061	CcSEcCtD
Fulvestrant—ESR1—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00313	0.0135	CbGpPWpGaD
Fulvestrant—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.0031	0.00592	CcSEcCtD
Fulvestrant—Insomnia—Telbivudine—hepatitis B	0.00308	0.00588	CcSEcCtD
Fulvestrant—Paraesthesia—Telbivudine—hepatitis B	0.00306	0.00583	CcSEcCtD
Fulvestrant—Depression—Lamivudine—hepatitis B	0.003	0.00572	CcSEcCtD
Fulvestrant—Dyspepsia—Telbivudine—hepatitis B	0.003	0.00572	CcSEcCtD
Fulvestrant—Asthenia—Entecavir—hepatitis B	0.00297	0.00567	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00294	0.00561	CcSEcCtD
Fulvestrant—Fatigue—Telbivudine—hepatitis B	0.00293	0.0056	CcSEcCtD
Fulvestrant—Pain—Telbivudine—hepatitis B	0.00291	0.00556	CcSEcCtD
Fulvestrant—Asthenia—Adefovir Dipivoxil—hepatitis B	0.0029	0.00554	CcSEcCtD
Fulvestrant—NR1H4—Biological oxidations—GGT2—hepatitis B	0.0029	0.0125	CbGpPWpGaD
Fulvestrant—Sweating—Lamivudine—hepatitis B	0.00288	0.0055	CcSEcCtD
Fulvestrant—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00286	0.00546	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Lamivudine—hepatitis B	0.00284	0.00543	CcSEcCtD
Fulvestrant—Diarrhoea—Entecavir—hepatitis B	0.00283	0.00541	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Telbivudine—hepatitis B	0.00278	0.00531	CcSEcCtD
Fulvestrant—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00277	0.00528	CcSEcCtD
Fulvestrant—ESR1—Nuclear Receptors—HNF4A—hepatitis B	0.00275	0.0119	CbGpPWpGaD
Fulvestrant—Dizziness—Entecavir—hepatitis B	0.00274	0.00523	CcSEcCtD
Fulvestrant—Hepatitis—Lamivudine—hepatitis B	0.0027	0.00515	CcSEcCtD
Fulvestrant—Body temperature increased—Telbivudine—hepatitis B	0.00269	0.00514	CcSEcCtD
Fulvestrant—Abdominal pain—Telbivudine—hepatitis B	0.00269	0.00514	CcSEcCtD
Fulvestrant—Pharyngitis—Lamivudine—hepatitis B	0.00268	0.00512	CcSEcCtD
Fulvestrant—Connective tissue disorder—Lamivudine—hepatitis B	0.00265	0.00506	CcSEcCtD
Fulvestrant—Vomiting—Entecavir—hepatitis B	0.00263	0.00503	CcSEcCtD
Fulvestrant—Rash—Entecavir—hepatitis B	0.00261	0.00499	CcSEcCtD
Fulvestrant—ESR1—Validated nuclear estrogen receptor alpha network—NR0B2—hepatitis B	0.00261	0.0113	CbGpPWpGaD
Fulvestrant—Dermatitis—Entecavir—hepatitis B	0.00261	0.00498	CcSEcCtD
Fulvestrant—Headache—Entecavir—hepatitis B	0.0026	0.00495	CcSEcCtD
Fulvestrant—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00257	0.00491	CcSEcCtD
Fulvestrant—NR1H4—Bile acid and bile salt metabolism—ALB—hepatitis B	0.00255	0.011	CbGpPWpGaD
Fulvestrant—Rash—Adefovir Dipivoxil—hepatitis B	0.00255	0.00487	CcSEcCtD
Fulvestrant—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00255	0.00486	CcSEcCtD
Fulvestrant—Headache—Adefovir Dipivoxil—hepatitis B	0.00253	0.00483	CcSEcCtD
Fulvestrant—Nausea—Entecavir—hepatitis B	0.00246	0.0047	CcSEcCtD
Fulvestrant—Asthenia—Telbivudine—hepatitis B	0.00244	0.00466	CcSEcCtD
Fulvestrant—Immune system disorder—Lamivudine—hepatitis B	0.00244	0.00466	CcSEcCtD
Fulvestrant—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00242	0.0104	CbGpPWpGaD
Fulvestrant—Pruritus—Telbivudine—hepatitis B	0.00241	0.0046	CcSEcCtD
Fulvestrant—Nausea—Adefovir Dipivoxil—hepatitis B	0.0024	0.00458	CcSEcCtD
Fulvestrant—Malnutrition—Lamivudine—hepatitis B	0.00235	0.00449	CcSEcCtD
Fulvestrant—CYP3A4—blood—hepatitis B	0.00234	0.00955	CbGeAlD
Fulvestrant—Diarrhoea—Telbivudine—hepatitis B	0.00233	0.00445	CcSEcCtD
Fulvestrant—Back pain—Lamivudine—hepatitis B	0.00227	0.00434	CcSEcCtD
Fulvestrant—Dizziness—Telbivudine—hepatitis B	0.00225	0.0043	CcSEcCtD
Fulvestrant—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00225	0.00971	CbGpPWpGaD
Fulvestrant—Anaemia—Lamivudine—hepatitis B	0.00217	0.00415	CcSEcCtD
Fulvestrant—ESR1—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.00217	0.00937	CbGpPWpGaD
Fulvestrant—Vomiting—Telbivudine—hepatitis B	0.00216	0.00413	CcSEcCtD
Fulvestrant—Angioedema—Lamivudine—hepatitis B	0.00215	0.0041	CcSEcCtD
Fulvestrant—Rash—Telbivudine—hepatitis B	0.00215	0.0041	CcSEcCtD
Fulvestrant—Dermatitis—Telbivudine—hepatitis B	0.00214	0.00409	CcSEcCtD
Fulvestrant—Headache—Telbivudine—hepatitis B	0.00213	0.00407	CcSEcCtD
Fulvestrant—Vertigo—Lamivudine—hepatitis B	0.00211	0.00403	CcSEcCtD
Fulvestrant—Leukopenia—Lamivudine—hepatitis B	0.0021	0.00402	CcSEcCtD
Fulvestrant—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hepatitis B	0.00209	0.00903	CbGpPWpGaD
Fulvestrant—Cough—Lamivudine—hepatitis B	0.00205	0.00391	CcSEcCtD
Fulvestrant—Nausea—Telbivudine—hepatitis B	0.00202	0.00386	CcSEcCtD
Fulvestrant—Arthralgia—Lamivudine—hepatitis B	0.002	0.00382	CcSEcCtD
Fulvestrant—Myalgia—Lamivudine—hepatitis B	0.002	0.00382	CcSEcCtD
Fulvestrant—Chest pain—Lamivudine—hepatitis B	0.002	0.00382	CcSEcCtD
Fulvestrant—Anxiety—Lamivudine—hepatitis B	0.00199	0.00381	CcSEcCtD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00199	0.00859	CbGpPWpGaD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00199	0.00379	CcSEcCtD
Fulvestrant—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TNF—hepatitis B	0.00195	0.00844	CbGpPWpGaD
Fulvestrant—Infection—Lamivudine—hepatitis B	0.00191	0.00364	CcSEcCtD
Fulvestrant—Nervous system disorder—Lamivudine—hepatitis B	0.00188	0.00359	CcSEcCtD
Fulvestrant—Skin disorder—Lamivudine—hepatitis B	0.00186	0.00356	CcSEcCtD
Fulvestrant—Hyperhidrosis—Lamivudine—hepatitis B	0.00185	0.00354	CcSEcCtD
Fulvestrant—Anorexia—Lamivudine—hepatitis B	0.00183	0.00349	CcSEcCtD
Fulvestrant—CYP3A4—liver—hepatitis B	0.00183	0.00747	CbGeAlD
Fulvestrant—NR1H4—Biological oxidations—CYP2A6—hepatitis B	0.00176	0.00759	CbGpPWpGaD
Fulvestrant—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00175	0.00334	CcSEcCtD
Fulvestrant—Insomnia—Lamivudine—hepatitis B	0.00173	0.00331	CcSEcCtD
Fulvestrant—Paraesthesia—Lamivudine—hepatitis B	0.00172	0.00329	CcSEcCtD
Fulvestrant—Dyspnoea—Lamivudine—hepatitis B	0.00171	0.00326	CcSEcCtD
Fulvestrant—Dyspepsia—Lamivudine—hepatitis B	0.00169	0.00322	CcSEcCtD
Fulvestrant—ESRRA—Generic Transcription Pathway—NR0B2—hepatitis B	0.00169	0.00728	CbGpPWpGaD
Fulvestrant—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00168	0.00726	CbGpPWpGaD
Fulvestrant—Decreased appetite—Lamivudine—hepatitis B	0.00167	0.00318	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00166	0.00316	CcSEcCtD
Fulvestrant—Fatigue—Lamivudine—hepatitis B	0.00165	0.00316	CcSEcCtD
Fulvestrant—Constipation—Lamivudine—hepatitis B	0.00164	0.00313	CcSEcCtD
Fulvestrant—Pain—Lamivudine—hepatitis B	0.00164	0.00313	CcSEcCtD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—APOBEC3G—hepatitis B	0.00163	0.00704	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00159	0.00686	CbGpPWpGaD
Fulvestrant—Gastrointestinal pain—Lamivudine—hepatitis B	0.00157	0.00299	CcSEcCtD
Fulvestrant—Urticaria—Lamivudine—hepatitis B	0.00152	0.00291	CcSEcCtD
Fulvestrant—Abdominal pain—Lamivudine—hepatitis B	0.00152	0.00289	CcSEcCtD
Fulvestrant—Body temperature increased—Lamivudine—hepatitis B	0.00152	0.00289	CcSEcCtD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—HNF4A—hepatitis B	0.0015	0.00647	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.0015	0.00646	CbGpPWpGaD
Fulvestrant—Hypersensitivity—Lamivudine—hepatitis B	0.00141	0.0027	CcSEcCtD
Fulvestrant—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.00141	0.00607	CbGpPWpGaD
Fulvestrant—Asthenia—Lamivudine—hepatitis B	0.00138	0.00263	CcSEcCtD
Fulvestrant—NR1H4—Biological oxidations—GGT1—hepatitis B	0.00137	0.00592	CbGpPWpGaD
Fulvestrant—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—hepatitis B	0.00136	0.00588	CbGpPWpGaD
Fulvestrant—Pruritus—Lamivudine—hepatitis B	0.00136	0.00259	CcSEcCtD
Fulvestrant—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00135	0.00584	CbGpPWpGaD
Fulvestrant—Diarrhoea—Lamivudine—hepatitis B	0.00131	0.00251	CcSEcCtD
Fulvestrant—Dizziness—Lamivudine—hepatitis B	0.00127	0.00242	CcSEcCtD
Fulvestrant—NR1H4—Generic Transcription Pathway—NR0B2—hepatitis B	0.00123	0.00532	CbGpPWpGaD
Fulvestrant—Vomiting—Lamivudine—hepatitis B	0.00122	0.00233	CcSEcCtD
Fulvestrant—ESR1—Estrogen signaling pathway—NFKB1—hepatitis B	0.00122	0.00525	CbGpPWpGaD
Fulvestrant—Rash—Lamivudine—hepatitis B	0.00121	0.00231	CcSEcCtD
Fulvestrant—Dermatitis—Lamivudine—hepatitis B	0.00121	0.00231	CcSEcCtD
Fulvestrant—Headache—Lamivudine—hepatitis B	0.0012	0.00229	CcSEcCtD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—IFNB1—hepatitis B	0.00118	0.00508	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—HNF4A—hepatitis B	0.00117	0.00504	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00116	0.00502	CbGpPWpGaD
Fulvestrant—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00114	0.00494	CbGpPWpGaD
Fulvestrant—Nausea—Lamivudine—hepatitis B	0.00114	0.00217	CcSEcCtD
Fulvestrant—ESR2—Generic Transcription Pathway—NR0B2—hepatitis B	0.00107	0.00463	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL10—hepatitis B	0.00107	0.0046	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL10—hepatitis B	0.00102	0.00441	CbGpPWpGaD
Fulvestrant—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000966	0.00417	CbGpPWpGaD
Fulvestrant—ESR1—FOXM1 transcription factor network—CDKN2A—hepatitis B	0.000926	0.004	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—hepatitis B	0.000908	0.00392	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000902	0.00389	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—HLA-A—hepatitis B	0.000899	0.00388	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—NOS2—hepatitis B	0.000897	0.00387	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—AKR1B1—hepatitis B	0.000885	0.00382	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—HNF4A—hepatitis B	0.000854	0.00369	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GGT2—hepatitis B	0.000849	0.00367	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000843	0.00364	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000813	0.00351	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—NR0B2—hepatitis B	0.000811	0.0035	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000755	0.00326	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—HNF4A—hepatitis B	0.000743	0.00321	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000721	0.00311	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—AKR1B1—hepatitis B	0.000708	0.00306	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000704	0.00304	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000699	0.00302	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—IFNG—hepatitis B	0.000688	0.00297	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GGT2—hepatitis B	0.000679	0.00293	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—CDKN2A—hepatitis B	0.000615	0.00266	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—IFNG—hepatitis B	0.000614	0.00265	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IFNG—hepatitis B	0.0006	0.00259	CbGpPWpGaD
Fulvestrant—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—hepatitis B	0.000596	0.00257	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NR0B2—hepatitis B	0.000593	0.00256	CbGpPWpGaD
Fulvestrant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000584	0.00252	CbGpPWpGaD
Fulvestrant—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000576	0.00249	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—HNF4A—hepatitis B	0.000562	0.00243	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—IL2—hepatitis B	0.000546	0.00236	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000543	0.00235	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NR0B2—hepatitis B	0.000541	0.00234	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000538	0.00232	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL2—hepatitis B	0.000533	0.0023	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000527	0.00227	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000522	0.00225	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—AKR1B1—hepatitis B	0.000517	0.00223	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NR0B2—hepatitis B	0.000516	0.00223	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—CTNNB1—hepatitis B	0.000515	0.00222	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CYP2A6—hepatitis B	0.000514	0.00222	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—NFKB1—hepatitis B	0.000511	0.00221	CbGpPWpGaD
Fulvestrant—ESR1—LKB1 signaling events—TP53—hepatitis B	0.000506	0.00218	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—PTEN—hepatitis B	0.000502	0.00217	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GGT2—hepatitis B	0.000496	0.00214	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.00048	0.00207	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000473	0.00204	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—NFKB1—hepatitis B	0.000473	0.00204	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GOT2—hepatitis B	0.000465	0.00201	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000457	0.00198	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hepatitis B	0.000447	0.00193	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000447	0.00193	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000446	0.00193	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000444	0.00192	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000427	0.00184	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—TGFB1—hepatitis B	0.000426	0.00184	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000425	0.00184	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—TGFB1—hepatitis B	0.000416	0.0018	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000415	0.00179	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CYP2A6—hepatitis B	0.000411	0.00178	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—HNF4A—hepatitis B	0.000411	0.00177	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.00041	0.00177	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000406	0.00175	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GOT1—hepatitis B	0.000401	0.00173	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GGT1—hepatitis B	0.000401	0.00173	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000383	0.00166	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—HNF4A—hepatitis B	0.000375	0.00162	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GOT2—hepatitis B	0.000372	0.00161	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.00037	0.0016	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000366	0.00158	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—IL6—hepatitis B	0.000359	0.00155	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—HNF4A—hepatitis B	0.000358	0.00155	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000345	0.00149	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—TP53—hepatitis B	0.000342	0.00148	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000327	0.00141	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GOT1—hepatitis B	0.000321	0.00139	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GGT1—hepatitis B	0.000321	0.00139	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL6—hepatitis B	0.000313	0.00135	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000304	0.00131	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP2A6—hepatitis B	0.0003	0.0013	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000292	0.00126	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.00028	0.00121	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000278	0.0012	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GOT2—hepatitis B	0.000272	0.00117	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000271	0.00117	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—CDKN1A—hepatitis B	0.00027	0.00117	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.00027	0.00117	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—PTEN—hepatitis B	0.00027	0.00117	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—ALB—hepatitis B	0.000266	0.00115	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NR0B2—hepatitis B	0.00026	0.00112	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000251	0.00109	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GGT1—hepatitis B	0.000235	0.00101	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GOT1—hepatitis B	0.000235	0.00101	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000231	0.000996	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000225	0.000973	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000225	0.000971	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000224	0.000966	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000214	0.000923	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ALB—hepatitis B	0.000214	0.000922	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SAG—hepatitis B	0.00021	0.000907	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RIT2—hepatitis B	0.00021	0.000907	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000196	0.000848	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000186	0.000805	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000185	0.0008	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HNF4A—hepatitis B	0.00018	0.000779	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000174	0.000751	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ALB—hepatitis B	0.000171	0.000737	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IL6—hepatitis B	0.000169	0.000728	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTEN—hepatitis B	0.000163	0.000704	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000153	0.000662	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTEN—hepatitis B	0.00013	0.000563	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ALB—hepatitis B	0.000125	0.000539	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTEN—hepatitis B	9.52e-05	0.000411	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL10—hepatitis B	8.29e-05	0.000358	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKR1B1—hepatitis B	7.4e-05	0.00032	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GGT2—hepatitis B	7.1e-05	0.000307	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR5—hepatitis B	6.43e-05	0.000278	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—F2—hepatitis B	5.52e-05	0.000238	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP2A6—hepatitis B	4.3e-05	0.000186	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GOT2—hepatitis B	3.89e-05	0.000168	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL2—hepatitis B	3.71e-05	0.00016	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CTNNB1—hepatitis B	3.59e-05	0.000155	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CDKN1A—hepatitis B	3.5e-05	0.000151	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTEN—hepatitis B	3.5e-05	0.000151	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NFKB1—hepatitis B	3.48e-05	0.00015	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GGT1—hepatitis B	3.36e-05	0.000145	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GOT1—hepatitis B	3.36e-05	0.000145	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TGFB1—hepatitis B	2.9e-05	0.000125	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TP53—hepatitis B	2.39e-05	0.000103	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6—hepatitis B	2.18e-05	9.43e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALB—hepatitis B	1.79e-05	7.71e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTEN—hepatitis B	1.36e-05	5.88e-05	CbGpPWpGaD
